A Ph3, Multicenter, Prospective, Randomized, Masked, Controlled, Safety/Efficacy Study of a Fluocinolone Acetonide Intravitreal 0.05 mg Insert (Yutiq 0.05 mg) in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Administered By

Awarded By

Contributors

Start/End

  • August 26, 2021 - July 31, 2023